Filter by category
Filter by tag
The Marketplace Diversity Assessment: Improving Diversity in Clinical Trials
The evidence-based diversity assessment allows sponsors to easily match their protocols to sites in the Inato Marketplace with expertise in diversity. Sites complete a 14-point assessment which evaluates three facets of diversity: community, research team, recruitment and outreach approach.
3 Steps to Secure More Clinical Trials at Your Site in the Next 12 Months
On Thursday June 18th between 12:00 - 1:00 pm EST, Inato hosted a discussion on how to secure more clinical trials for your site
Growing From A Feasibility Platform To A Clinical Trials Marketplace
Inato's strategic transition from a feasibility platform to offering a two-sided marketplace that matches clinical research sites to the sponsor trials best suited for them
Cutting Through the Chaos to Navigate Corona Virus Disease Clinical Trials
Doctors grappling with fragmented data sources on COVID-19 trials can use Inato's Anticovid Platform to search trials, analyze trends, and act effectively
Interview with Christophe Massard, MD PhD
Christophe Massard, MD PhD is a medical oncologist and the department head at Drug Development Department (DITEP) in Paris, France. He is a member of ESMO, ASCO and AACR and has participated in over 130 trials in the past five years. His research focuses on early clinical trials, precision medicine, GU cancers (prostate, bladder and testis) and glioblastoma.
A Sanofi case study in lung cancer
How to dramatically accelerate clinical trials and sustain lower costs in complex and competitive environments